ECO3 Hyperthermia Cancer Breakthrough

January 26, 2010

BioScience Research Institute has taken Hyperthermia and Ozone treatments to a new level by creating a proprietary system which incorporates them both.

ECO3 Technique

Blood is extracted in a constant flow and heated up to 45 degrees C by the ECO3 system. An Ozonification & UV device, which integrates Ozone into the blood, then processes the blood; the end result is a hyper-oxygenated-heated mixture. Before returning to the body it passes trough a detoxification filter, which will cleanse the blood of toxins and cellular debris.

The grand majority of clinical studies done in both Europe and the U.S, state that in order for hyperthermia to obtain maximum results, the body must be exposed to the desired temperature (43 degrees C) for a length of 2-3 hours.

During the procedure the patient is monitored by trained staff and by the ECO3 System at all times. Due to the highly technical and complex nature of the procedure, this therapy requires that it be done strictly in a hospital-controlled environment.

Effects of ECO3 Hyperthermia in Cancer Cells

The idea of using heat to treat cancer has been around for some time, but early attempts to treat cancer with heat had mixed results. And it was hard to maintain the right temperature in the right area while limiting the effects on other parts of the body. Today, the ECO3 system allows us to have better control and more precise delivery of heat.

When cells in the body are exposed to higher than normal temperatures, changes take place inside the cells. These changes can make the cells more likely to be affected by orthomolecular cancer treatments. Hyperthermic Ozonification in tumor cells causes an overexposure of oxygen. This results in over-acidification of the heated cells and a lack of nutrients in the tumor. The cell metabolism is destroyed, resulting in cell death (apoptosis) of the tumor cells.

Under normal conditions, tumor cells are invisible for the immune system. But they change under the influence of heat and UV exposure. They then form “heat shock proteins”, certain proteins which appear on the surface of the degenerated cells. The body’s own immune system detects these proteins as extraneous cells, giving a clear indication for the immune cells to fight the cancer cells. Healthy cells do not form heat shock proteins.

Unlike healthy human cells that love oxygen, Cancer virions and Cancer cells, are anaerobic. Anaerobic cells cannot live in high oxygen concentrations. Malignant cells have an increased rate of glycolysis which leads to the production of more lactate. With ozone therapy, there is a significant decrease in lactate production, showing that the metabolism is being inhibited Tumor cells have a peroxide intolerance due to insufficient peroxidase and catalase. Ozone is thus able to oxidize the outer lipid layer of malignant cells and destroy them through cell lysis.

The ECO3 Hyperthermia is used as a cornerstone of our program and has been proven to have phenomenal synergistic effects with the rest of our treatment approach.

For more information and to determine if you are a candidate for this breakthrough treatment, please contact Tina Jenkins at 1800.211.0690 or send an email to info@bioscienceresearchinstitute.com


Cancer and Vitamin C

October 15, 2009

A number of case-control studies have investigated the role of vitamin C in cancer prevention. Most have shown that higher intakes of vitamin C are associated with decreased incidence of cancers of the mouth, throat and vocal chords, esophagus, stomach, colon-rectum, and lung. Because the possibility of bias is greater in case-control studies, prospective studies are generally given more weight in the evaluation of the effect of nutrient intake on disease. In general, prospective studies in which the lowest intake group consumed more than 86 mg of vitamin C daily have not found differences in cancer risk, while studies finding significant cancer risk reductions found them in people consuming at least 80 to 110 mg of vitamin C daily .

A prospective study of 870 men over a period of 25 years found that those who consumed more than 83 mg of vitamin C daily had a striking 64% reduction in lung cancer compared with those who consumed less than 63 mg per day. Although most large prospective studies found no association between breast cancer and vitamin C intake, two recent studies found dietary vitamin C intake to be inversely associated with breast cancer risk in certain subgroups. In the Nurses’ Health Study, premenopausal women with a family history of breast cancer who consumed an average of 205 mg/day of vitamin C from foods had a 63% lower risk of breast cancer than those who consumed an average of 70 mg/day. In the Swedish Mammography Cohort, women who were overweight and consumed an average of 110 mg/day of vitamin C had a 39% lower risk of breast cancer compared to overweight women who consumed an average of 31 mg/day. A number of observational studies have found increased dietary vitamin C intake to be associated with decreased risk of stomach cancer, and laboratory experiments indicate that vitamin C inhibits the formation of carcinogenic compounds in the stomach. Infection with the bacteria, helicobacter pylori (H. pylori) is known to increase the risk of stomach cancer and also appears to lower the vitamin C content of stomach secretions. Although two intervention studies did not find a decrease in the occurrence of stomach cancer with vitamin C supplementation, more recent research suggests that vitamin C supplementation may be a useful addition to standard H. pylori eradication therapy in reducing the risk of gastric cancer.

Evidence suggest that the more vitamin C that you ingest in your diet, the more healthier you will be in all parameters. in bioscience vitamin C is widely used in many of our programs, we use high/mega dose iv therapy for health issues, such as treatment of infections, heavy metal toxicity, cancer, wellness, joint support and health, immune support, detoxification, just to mention some.

Is Infection a cause for Multiple Sclerosis?

October 14, 2009

Multiple Sclerosis (MS) is a disease of the nerves of the central nervous system, and it can occur in young as well as older people.

A possible infectious cause for MS has been under investigation for approximately the last decade.25-27 Epidemiological and twin studies suggest that MS is acquired not inherited. Since more than 90% of Multiple Sclerosis patients show immunological and cytokine characteristic of infection, Multiple Sclerosis patients have been examined for various viral ( Human Herpes Virus-6) and bacterial infections (Mycoplasma, Chlamydia Borrelia burgdorferi).

Recent research at the Institute for Molecular Medicine and elsewhere has shown that autoimmune responses to nerve cell proteins may be caused, in part, by intracellular bacterial infections.

Since infections usually stimulate immunological responses, the presence of intracellular bacterial infections in nerve cells, in particular, may stimulate autoimmune responses against nerve cell antigens. In the case of Multiple Sclerosis, some 20 different bacterial and viral infections have been found, but the link between these infections and the pathogenesis of MS is still being debated. Perhaps this is the reason that one or even a few types of infections cannot be linked to every case of MS. That, however, does not prove that infections, in general, are not linked to the pathogenesis of Multiple Sclerosis.

Bioscience takes this into account, our systemic ozone therapy, which destroys microorganisms such as fungus, bacteria and virus. our protocol is built understanding that MS is a multifactorial disease and can be due to several reasons, infections being one of them. there for that our treatment incorporates the most breakthrough treatments available. raging from nutritional support to stem cell therapy, targeting the most important aspects of the disease, balancing the immune response, lowering inflammation and rebuilding of the myelin sheet.

Stem Cells bring hope to Multiple sclerosis patients

October 8, 2009
Stem cell therapy will soon emerge on its own as an entirely new branch of medicine.  Soon instead of taking potentially poisonous medications, you will be able to get an injection from a local stem cell center of fresh customized targeted stem cells.

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types by two important characteristics. First, they are non-specific cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.

BioScience approach to MS using Stem Cells

BioScience physicians are working on reversing some of the disabilities associated with Multiple Sclerosis.  BioScience physicians essentially eliminate misbehaving immune cells and replace them with healthy ones, the treatment works by resetting the patients’ immune system by using their own stem cells.

At BioScience, doctors achieve this by giving their patients non-aggressive drugs that prompt their bone marrow to release immune stem cells (which have the ability to morph into any type of immune cell) into the blood; they then extract the cells from the blood and give the patients a treatment to wipe out an overactive immune system. Physicians then inject the patient with their stem cells that had been removed earlier; the stem cells quickly divide, giving rise to a fresh batch of normal immune cells.

The whole idea behind our treatments is to focus on regenerating a new immune system that recognizes healthy tissue and does not destroy the protein sheaths.

The use of stem cells for chronic degenerative conditions such as Multiple Sclerosis has made Excel Medical Center THE place to go for treatment.


Follow

Get every new post delivered to your Inbox.